GATX Corporation reported robust financial results for the fourth quarter of 2024, with earnings per share (EPS) of $1.93, surpassing the forecast of $1.69. Revenue also exceeded expectations, coming in at $413.

Johnson & Johnson’s JNJ fourth-quarter 2024 earnings came in at $2.04 per share, which beat the Zacks Consensus Estimate of $2.00. Earnings declined 10.9% from the year-ago period. Adjusted earnings exclude intangible amortization expense and special items,

Shares of Johnson & Johnson fell over 2% on Wednesday, hitting nearly one-week lows, despite reporting better-than-expected fourth-quarter (Q4) earnings. The pharmaceutical giant posted Q4 adjusted earnings of $2.